256 findings · Molecular · published 2017+
- MolecularStrong
AM833 has a unique pharmacological profile across diverse measures of receptor binding, activation, and regulation.
Understanding AM833's unique profile can inform its therapeutic use.
Supports 2021 - MolecularStrong
Arachidonic acid (AA) levels were not associated with higher risk of cardiovascular outcomes, and higher levels were associated with lower risk of total CVD with a hazard ratio of 0.92 (95% CI, 0.86-0.99).
Arachidonic acid may not increase cardiovascular risk and could be beneficial at higher levels.
Qualifies 2019 - MolecularStrong
Insulin sensitizers such as PPARγ (pioglitazone) and pan-PPARs agonists (lanifibranor) have shown beneficial effects on both NASH and liver fibrosis.
Consider insulin sensitizers as part of the treatment plan for NASH and liver fibrosis.
Supports 2022 - MolecularStrong
The hazard ratio of type 2 diabetes per increment of 10 risk alleles in the polygenic risk score is 1.64 (95% CI 1.54 to 1.75).
Genetic predisposition significantly increases the risk of developing type 2 diabetes.
Supports 2019 - MolecularStrong
The LCT genotype with 1 or 2 T allele was significantly associated with higher dairy intake and higher BMI.
Genetic factors may influence how dairy intake affects BMI.
Supports 2017 - MolecularStrong
Micronutrients like polyphenols, carotenoids, and vitamins affect oxidative stress, endothelial function, and lipid and glucose homeostasis.
Encouraging the intake of micronutrient-rich foods may support cardiovascular health.
Supports 2018 - MolecularStrong
ω-3-PL/FFA was well tolerated with a safety profile similar to that of placebo.
Practitioners can confidently recommend ω-3-PL/FFA as a safe option for patients.
Supports 2022 - MolecularStrong
Higher levels of circulating behenic acid are associated with a 15% lower risk of unhealthy aging events.
Practitioners may consider monitoring behenic acid levels as a potential marker for healthy aging.
Supports 2021 - MolecularStrong
Higher levels of circulating lignoceric acid are associated with a 16% lower risk of unhealthy aging events.
Practitioners may consider monitoring lignoceric acid levels as a potential marker for healthy aging.
Supports 2021 - MolecularStrong
The study highlights the need to explore determinants of circulating very-long-chain saturated fatty acids (VLSFAs) for promoting healthy aging.
Practitioners and researchers should consider investigating VLSFAs further to enhance strategies for healthy aging.
Supports 2021 - MolecularStrong
Stable isotope tracers have significantly advanced the understanding of muscle protein turnover.
Utilizing stable isotope tracers can enhance research and understanding of muscle protein metabolism.
Supports 2021 - MolecularStrong
The study of exercise as a preventative or therapeutic treatment is increasingly interdisciplinary and impactful.
Researchers and practitioners should collaborate across disciplines to enhance exercise interventions.
Supports 2022 - MolecularStrong
MYOD1, MYF5, and MYF6 mean methylation was reduced after 4 and 8 hours in response to all exercise protocols.
Resistance, high-intensity interval, and concurrent exercise can effectively reduce DNA methylation in myogenic regulatory factors.
Supports 2022 - MolecularStrong
Changes in DNA methylation and mRNA expression were largely confined to the late (4-8 h) recovery period.
Recovery periods after exercise are critical for observing changes in muscle regulatory factors.
Supports 2022 - MolecularStrong
High-circulating lipid availability results in lower peak aminoacidemia following protein ingestion.
Understanding the impact of lipid levels on amino acid availability can inform dietary strategies.
Supports 2019 - MolecularStrong
Semaglutide has a higher pooled reporting odds ratio (ROR) for gastrointestinal adverse drug reactions (GADRs) compared to liraglutide (5.53 vs 3.95).
Clinicians should consider the higher gastrointestinal risk associated with semaglutide when prescribing.
Supports 2022 - MolecularStrong
Semaglutide has a later pooled time-to-onset median of GADRs compared to liraglutide (7 days vs 4 days).
Healthcare providers should be aware of the delayed onset of gastrointestinal issues with semaglutide.
Supports 2022 - MolecularStrong
DEPTOR is identified as a critical mechanistic candidate for disuse-driven MPS suppression.
Targeting DEPTOR may offer a therapeutic approach to counteract muscle loss during periods of disuse.
Supports 2021 - MolecularStrong
Metabolic dysregulation is linked to ectopic fat deposition and alterations in immune cell populations in adipose tissue among PWH.
Understanding these links can help in developing targeted interventions for obesity in PWH.
Supports 2023 - MolecularStrong
Post-exercise changes in proteins reflective of protein synthesis were similar between groups, though some mRNA exhibited exercise order-dependent responses.
Understanding the molecular responses can help tailor exercise programs for optimal protein synthesis.
Qualifies 2023 - MolecularStrong
There is a surge of interest in unimolecular peptide hormone-based polypharmacy for obesity management.
Practitioners should stay informed about developments in peptide hormone therapies for obesity.
Supports 2022 - MolecularStrong
Excessive consumption of industrial seed oils rich in linoleic acid contributes to mitochondrial dysfunction.
Reducing intake of linoleic acid-rich oils may be beneficial for mitochondrial health.
Supports 2025New - MolecularStrong
Plasma myristic acid, linoelaidic acid, linoleic acid, α-linoleic acid, pentadecanoic acid, alanine, proline, carnitine, and deoxycarnitine increased among participants following a Western diet.
These metabolites can indicate adherence to a Western diet and its potential health impacts.
Supports 2019 - MolecularStrong
GLP-1 receptor agonists and GLP-1/GIP biagonists reduce the expression of genes involved in lipogenesis in adipose tissue.
These drugs may help in managing fat storage by altering gene expression.
Supports 2024